SCHEMBL16403103

SCHEMBL16403103

CNC1CCNC(c2ccccc2)C1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 6/20 0.45
MAOB P27338 3/20 0.45
CISD1 Q9NZ45 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR1B P28222 1/20 0.41
HTR2A P28223 1/20 0.41
SLC6A4 P31645 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
MAOA P21397 1/20 0.40
SLC18A3 Q16572 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
PRCP P42785 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30141966 1.00 KDM1A (0.45) KDM1AMAOBCISD1SLC6A2HTR1B
SCHEMBL25053490 0.83 KDM1A (0.34) KDM1AMAOBSLC6A2SLC6A4PRCP
SCHEMBL25052830 0.82 KCNH2 (0.40) KDM1AMAOBCISD1SLC6A2HTR1B
SCHEMBL8085859 0.80 SMN1; SMN2 (0.49) KDM1AMAOBCISD1SLC6A2HTR1B
SCHEMBL22032451 0.79 KDM1A (0.40) KDM1AMAOBCISD1SLC6A2HTR1B
SCHEMBL16401194 0.79 KDM1A (0.40) KDM1AMAOBCISD1SLC6A2HTR1B
SCHEMBL22032415 0.79 KDM1A (0.40) KDM1AMAOBCISD1SLC6A2HTR1B
SCHEMBL29324146 0.78 GRIN2B (0.47) KDM1ASLC6A4MAOAMEN1KMT2A
SCHEMBL29081462 0.78 GRIN2B (0.47) KDM1ASLC6A4MAOAMEN1KMT2A
SCHEMBL25053184 0.78 KDM1A (0.47) KDM1ASIGMAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3022192-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS Novartis AG (CH) 2016-05-25 EP claimed
WO-2015009616-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS NOVARTIS AG (CH) 2015-01-22 WO claimed
EP-3022192-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS Novartis AG (CH) 2016-05-25 EP disclosed
WO-2015009616-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS NOVARTIS AG (CH) 2015-01-22 WO disclosed